The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

CLIN CLINIGEN GROUP PLC ORD 0.1P



Income Statement  (£ m) 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14 30-Jun-15
Continuing Operations
Revenue  35.02 82.15 122.58 126.64 184.36
Operating Profit/(Loss)  7.14 10.54 14.60 21.52 9.18
Net Interest  0.39 0.28 0.10 0.23 0.86
Profit Before Tax  6.75 10.25 14.51 21.28 8.36
Profit After Tax  4.32 6.60 11.33 16.21 5.69
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  4.32 6.60 11.33 16.21 5.69
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  4.32 6.60 11.33 16.21 5.69
 
Continuing EPS
Earnings per Share - Basic  5.23p 13.20p 15.10p 19.60p 6.50p
Earnings per Share - Diluted  5.23p 8.70p 13.80p 19.00p 6.30p
Earnings per Share - Adjusted  5.23p 13.40p 20.10p 24.50p 28.00p
Continuing and Discontinued EPS
Earnings per Share - Basic  5.23p 13.20p 15.10p 19.60p 6.50p
Earnings per Share - Diluted  5.23p 8.70p 13.80p 19.00p 6.30p
Earnings per Share - Adjusted  5.23p 13.40p 20.10p 24.50p 28.00p
 
Dividend per Share  0.00p 0.00p 0.60p 3.00p 3.20p

Balance Sheet  (£ m) 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14 30-Jun-15
Assets
Non-Current Assets
Property, Plant & Equipment  0.07 0.43 0.75 0.97 1.60
Intangible Assets  14.68 15.34 38.89 50.51 308.22
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.22 10.12 1.98 1.96 3.84
  14.96 25.90 41.62 53.43 313.66
Current Assets
Inventories  0.90 2.79 3.15 2.47 11.13
Trade & Other Receivables  3.89 14.56 22.65 27.18 67.13
Cash at Bank & in Hand  10.01 5.20 11.33 21.79 27.75
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  14.80 22.55 37.13 51.43 106.01
 
Total Assets  29.76 48.45 78.75 104.86 419.67
 
Liabilities
Current Liabilities
Borrowings  -1.18 -1.63 0.00 -16.50 -69.47
Other Current Liabilities  -14.16 -16.92 -27.80 -22.06 -92.06
  -15.34 -18.54 -27.80 -38.56 -161.53
 
Net Current Assets  -0.54 4.01 9.33 12.88 -55.52
 
Non-Current Liabilities
Borrowings  -4.13 0.00 0.00 0.00 -34.53
Provisions  0.00 0.00 0.00 0.00 -18.99
Other Non-Current Liabilities  0.00 0.00 0.00 0.00 0.00
  -4.13 0.00 0.00 0.00 -53.52
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -19.47 -18.54 -27.80 -38.56 -215.05
 
Net Assets  10.29 29.91 50.95 66.31 204.63
 
Capital & Reserves
Share Capital  0.00 0.00 0.08 0.08 0.11
Share Premium Account  0.00 0.00 8.66 8.66 141.02
Other Reserves  5.48 5.51 5.52 4.94 5.15
Retained Earnings  4.81 24.40 36.69 52.62 58.35
Shareholders Funds  10.29 29.91 50.95 66.31 204.63
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  10.29 29.91 50.95 66.31 204.63

Ratios - based on IFRS 30-Jun-11 30-Jun-12 30-Jun-13 30-Jun-14 30-Jun-15
Continuing Operations
PE Ratio - Adjusted  n/a n/a 14.93 15.42 22.27
PEG - Adjusted  n/a n/a 0.30 0.70 1.56
Earnings per Share Growth - Adjusted  373.12% 156.31% 50.00% 21.89% 14.29%
Dividend Cover  n/a n/a 33.50 8.17 8.75
Revenue Per Share  42.42p 164.03p 163.84p 153.40p 211.32p
Pre-Tax Profit per Share  8.18p 20.47p 19.40p 25.78p 9.58p
Operating Margin  20.40% 12.83% 11.91% 16.99% 4.98%
Return on Capital Employed  774.00% 65.08% 121.15% 66.62% 47.51%
 
Continuing & Discontinued Operations
Dividend Yield  n/a n/a 0.20% 0.79% 0.51%
Dividend per Share Growth  n/a n/a n/a 400.00% 6.67%
Net Asset Value per Share (exc. Intangibles)  -5.32p 17.64p 14.60p 19.14p -94.43p
Net Gearing  -45.66% -11.94% -22.23% -7.97% 37.26%

Data is provided by Morningstar



Company Information
Updated Monthly
Company address Pitcairn House, Crown Square, Centrum 100, Burton-on-Trent, DE14 2WW, United Kingdom
Company website http://www.clinigengrou...
Market cap(in millions)* £ 745.74
Listing/Admission to trading 25 Sep 2012
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
24-Aug-16
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 3,000
SEDOL B89J241
ISIN number GB00B89J2419



CLINIGEN share fundamentals (CLIN)